Chemoinformaics analysis of
15-O-acetylbruceolide
Molecular Weight | 480.466 | nRot | 2 |
Heavy Atom Molecular Weight | 452.242 | nRig | 28 |
Exact Molecular Weight | 480.163 | nRing | 5 |
Solubility: LogS | -3.094 | nHRing | 2 |
Solubility: LogP | 0.01 | No. of Aliphatic Rings | 5 |
Acid Count | 0 | No. of Aromatic Rings | 0 |
Base Count | 0 | No. of Aliphatic Carbocycles Rings | 3 |
Atoms Count | 62 | No. of Aliphatic Hetero Cycles | 2 |
No. of Heavy Atom | 34 | No. of Aromatic Carbocycles | 0 |
nHetero | 11 | No. of Aromatic Hetero Cycles | 0 |
nBridge Head | 2 | No. Saturated Carbocycles | 2 |
No. of Hydrogen atom | 28 | No. of Saturated Hetero Cycles | 2 |
No. of Carbon atom | 23 | No. of Saturated Rings | 4 |
No. of Nitrogen atom | 0 | No. of Arom Atom | 0 |
No. of Oxygen atom | 11 | No. of Arom Bond | 0 |
nHA | 11 | APOL | 65.9022 |
nHD | 3 | BPOL | 38.5058 |
QED | 0.281 |
Synth | 6.449 |
Natural Product Likeliness | 3.517 |
NR-PPAR-gamma | 0.55 |
Lipinski | Accepted |
Pfizer | Accepted |
GSK | Rejected |
Golden Triangle | Accepted |
Pgp-inh | 0.994 |
Pgp-sub | 0.55 |
HIA | 0.868 |
CACO-2 | -5.321 |
MDCK | 0.0000931 |
BBB | 0.624 |
PPB | 0.307342 |
VDSS | 0.351 |
FU | 0.649158 |
CYP1A2-inh | 0.002 |
CYP1A2-sub | 0.718 |
CYP2c19-inh | 0.007 |
CYP2c19-sub | 0.681 |
CYP2c9-inh | 0.001 |
CYP2c9-sub | 0.04 |
CYP2d6-inh | 0.005 |
CYP2d6-sub | 0.115 |
CYP3a4-inh | 0.099 |
CYP3a4-sub | 0.239 |
CL | 3.166 |
T12 | 0.099 |
hERG | 0.002 |
Ames | 0.021 |
ROA | 0.525 |
SkinSen | 0.012 |
Carcinogencity | 0.047 |
EI | 0.007 |
Respiratory | 0.083 |
NR-Aromatase | 0.012 |
Antiviral | Yes |
Prediction | 0.759779 |